NZ210699A - Isolation of an osteogenic protein of the p3 immunologically related family - Google Patents

Isolation of an osteogenic protein of the p3 immunologically related family

Info

Publication number
NZ210699A
NZ210699A NZ210699A NZ21069984A NZ210699A NZ 210699 A NZ210699 A NZ 210699A NZ 210699 A NZ210699 A NZ 210699A NZ 21069984 A NZ21069984 A NZ 21069984A NZ 210699 A NZ210699 A NZ 210699A
Authority
NZ
New Zealand
Prior art keywords
isolation
protein
osteogenic protein
related family
immunologically related
Prior art date
Application number
NZ210699A
Other languages
English (en)
Inventor
Sen Arup
Original Assignee
Int Genetic Eng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Genetic Eng filed Critical Int Genetic Eng
Publication of NZ210699A publication Critical patent/NZ210699A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Magnetic Heads (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ210699A 1984-01-04 1984-12-21 Isolation of an osteogenic protein of the p3 immunologically related family NZ210699A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56816784A 1984-01-04 1984-01-04

Publications (1)

Publication Number Publication Date
NZ210699A true NZ210699A (en) 1989-06-28

Family

ID=24270176

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ210699A NZ210699A (en) 1984-01-04 1984-12-21 Isolation of an osteogenic protein of the p3 immunologically related family

Country Status (11)

Country Link
EP (1) EP0148155B1 (cg-RX-API-DMAC7.html)
JP (1) JPS60226814A (cg-RX-API-DMAC7.html)
AT (1) ATE42309T1 (cg-RX-API-DMAC7.html)
AU (1) AU580975B2 (cg-RX-API-DMAC7.html)
CA (1) CA1241641A (cg-RX-API-DMAC7.html)
DE (1) DE3569542D1 (cg-RX-API-DMAC7.html)
DK (1) DK161524C (cg-RX-API-DMAC7.html)
GR (1) GR850006B (cg-RX-API-DMAC7.html)
IE (1) IE57966B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ210699A (cg-RX-API-DMAC7.html)
ZA (1) ZA8547B (cg-RX-API-DMAC7.html)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795804A (en) * 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
US4627982A (en) * 1984-07-16 1986-12-09 Collagen Corporation Partially purified bone-inducing factor
JPH0723322B2 (ja) * 1985-12-07 1995-03-15 克之 藤井 液状骨形成剤からなる注射液
IL83003A (en) * 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US4877864A (en) * 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US6432919B1 (en) 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
EP0271668B1 (de) * 1986-10-22 1991-12-18 Gesellschaft für Biotechnologische Forschung mbH (GBF) Wachstumstimulierendes Material, Herstellungsverfahren und therapeutische Zusammensetzung
AU3433989A (en) * 1988-04-06 1989-11-03 Celtrix Laboratories, Inc. Bone-inducing protein
US5324819A (en) * 1988-04-08 1994-06-28 Stryker Corporation Osteogenic proteins
US5250302A (en) * 1988-04-08 1993-10-05 Stryker Corporation Osteogenic devices
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
EP0362367B1 (en) * 1988-04-08 1996-02-28 Stryker Corporation Osteogenic devices
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
US4968590A (en) * 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
US5108753A (en) * 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5670336A (en) * 1988-04-08 1997-09-23 Stryker Corporation Method for recombinant production of osteogenic protein
US4975526A (en) * 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
US5162114A (en) * 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
IL90683A0 (en) * 1988-06-27 1990-01-18 Yissum Res Dev Co Osteogenic growth factors derived from regenerating bone marrow
US5106626A (en) * 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors
JPH03151877A (ja) * 1989-06-02 1991-06-28 Chiron Corp 骨カルシウム沈着因子
CA2020729A1 (en) * 1989-07-19 1991-01-20 Michael C. Kiefer Bone morphogenetic protein
WO1991005802A1 (en) * 1989-10-17 1991-05-02 Creative Biomolecules, Inc. Osteogenic devices
US5645591A (en) * 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US6949505B1 (en) 1991-03-11 2005-09-27 Curis, Inc. Morphogen-induced dendritic growth
CA2104678C (en) 1991-03-11 2002-05-14 Charles M. Cohen Protein-induced morphogenesis
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US6090776A (en) * 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
US5656593A (en) * 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US6495513B1 (en) 1991-03-11 2002-12-17 Curis, Inc. Morphogen-enhanced survival and repair of neural cells
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5652118A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US5849686A (en) * 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US5972884A (en) * 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5739107A (en) 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5652337A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
US6022853A (en) * 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
JP3504263B2 (ja) 1991-11-04 2004-03-08 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー 組み換え型骨形態形成蛋白ヘテロダイマー、組成物および使用法
KR100227406B1 (ko) 1993-05-12 1999-12-01 브루스 엠. 에이센 Bmp-11 조성물
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
JP3717930B2 (ja) 1993-12-07 2005-11-16 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー Ｂｍｐ−１２、ｂｍｐ−１３およびそれらの腱誘導組成物
US5928940A (en) * 1996-09-24 1999-07-27 Creative Biomolecules, Inc. Morphogen-responsive signal transducer and methods of use thereof
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
CA2386408A1 (en) 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
AU2003240196A1 (en) 2002-06-20 2004-01-23 Nicolaas Duneas Osteoinductive biomaterials
CN1878565B (zh) 2003-09-12 2011-01-12 惠氏公司 用于递送成骨蛋白的注射型磷酸钙固体小棒剂和糊剂
CA2535169A1 (en) 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
AU2005266875B2 (en) 2004-07-23 2012-07-26 Acceleron Pharma Inc. ActRII receptor polypeptides, methods and compositions
EP1942960B1 (en) 2005-11-01 2012-08-29 Warsaw Orthopedic, Inc. Methods for producing bone matrix composition
TW201940502A (zh) 2007-02-02 2019-10-16 美商艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
WO2008157497A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Method of treating tissue
AU2008265850B2 (en) 2007-06-15 2014-06-26 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
WO2008157492A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
US9358113B2 (en) 2007-07-10 2016-06-07 Warsaw Orthopedic, Inc. Delivery system
CA2702499A1 (en) 2007-10-19 2009-04-23 Osteotech, Inc. Demineralized bone matrix compositions and methods
WO2010093950A1 (en) 2009-02-12 2010-08-19 Osteotech, Inc. Delivery system cartridge
JP6267425B2 (ja) 2009-11-17 2018-01-24 アクセルロン ファーマ， インコーポレイテッド 筋ジストロフィー治療のためのユートロフィン誘導に関するａｃｔｒｉｉｂタンパク質およびその改変体およびその使用
CN110036025B (zh) 2016-10-05 2024-03-22 阿塞勒隆制药公司 变体ActRIIB蛋白及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US4608199A (en) * 1984-03-20 1986-08-26 Arnold Caplan Bone protein purification process

Also Published As

Publication number Publication date
JPS60226814A (ja) 1985-11-12
EP0148155B1 (en) 1989-04-19
IE850010L (en) 1985-07-04
DK161524B (da) 1991-07-15
EP0148155A2 (en) 1985-07-10
IE57966B1 (en) 1993-06-02
AU580975B2 (en) 1989-02-09
GR850006B (cg-RX-API-DMAC7.html) 1985-05-03
AU3722184A (en) 1985-07-11
ATE42309T1 (de) 1989-05-15
DK161524C (da) 1991-12-23
DE3569542D1 (en) 1989-05-24
EP0148155A3 (en) 1986-08-13
CA1241641A (en) 1988-09-06
DK2285D0 (da) 1985-01-02
DK2285A (da) 1985-07-05
ZA8547B (en) 1986-09-24

Similar Documents

Publication Publication Date Title
NZ210699A (en) Isolation of an osteogenic protein of the p3 immunologically related family
HUT45695A (en) Compositions for determining growth of plants and process for producing 5-acylamino-pyrazol derivatives as active components
HUT51279A (en) Process for producing 2-phosphate-esters of ascorbinic acid and pharmaceutical compositions containing them as active components
PL275089A1 (en) Method of obtaining novel pharmaceutical compositions
HUT45252A (en) Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them as active components
NZ225976A (en) Method of preserving hay quality by addition of bacillus pumilus and compositions thereof
EP0270980A3 (en) Arrangement of fly wheels
HUT45540A (en) Process for producing beta-lactame compounds and pharmaceutical compositions containing them as active componenets
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
GB8816096D0 (en) New method & compositions of matter
HUT46930A (en) Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components
MY103562A (en) Somatic embryogenesis and plant regeneration of cacao
ZA844859B (en) Compositions for and method of increasing harvest yield
EP0320239A3 (en) Method of preparation of inoculum sections for plant tissue culture
HUT48885A (en) Process for producing nukleotid-analogues and pharmaceutical compositions containing them as active components
ZA887615B (en) Method of safening fungicidal compositions thereof
PT85278A (fr) Procede de preparation d:une fraction immunogene active a liegard des bilharzioses et de compositions immunisantes la contenant
GB8827831D0 (en) Compositions for reduction of phlebectasiae & process for preparing same
GB2210765B (en) Method of plant culture
HUT37785A (en) Process for producing 3-alkoxy-2-pyrrolidino-n-pyrimidinyl-or -n-pyrazinyl-propyl-amines and pharmaceutical compositions containing them as active agents
HUT44073A (en) Process for producing purified human angiogene factor and pharmaceutical compositions containing them
GB8728748D0 (en) Method of preparing 4-trifluoromethyl-2-nitrobenzoic acid & novel isomer
GB8804761D0 (en) Treatment of alcohol & alcoholic compositions
AR243056A1 (es) Composiciones sinergicas de sustancias activas para deshojar plantas y composiciones defoliadoras que las contienen.
AU8282987A (en) Composition for defoliation of plants i